Biofabricated Nanoparticle Coating for Liver-Cell Targeting.

Printer-friendly versionPrinter-friendly versionPDF versionPDF version
TitleBiofabricated Nanoparticle Coating for Liver-Cell Targeting.
Publication TypeJournal Article
Year of Publication2015
AuthorsZhang, C, Qu, X, Li, J, Hong, H, Li, J, Ren, J, Payne, GF, Liu, C
JournalAdv Healthc Mater
Date Published2015 Jul 2
ISSN2192-2659
Abstract<p>Biology routinely uses noncovalent interactions to perform complex functions that range from the molecular recognition of ligand-receptor binding to the reversible self-assembly/disassembly of hierarchical nanostructures (e.g., virus particles). Potentially, biological materials that offer such recognition and reversible self-assembly functionality can be applied to nanomedicine. Here, polysaccharides with the multifunctional polysaccharide-binding protein Concanavalin A (Con A) are coupled to create a functional nanoparticle coating. This coating is self-assembled in a layer-by-layer format by sequentially contacting a nanoparticle with Con A and the polysaccharide glycogen. In the final assembly step, a galactomannan targeting ligand is self-assembled into the coating. Evidence indicates that the mannose residues of the galactomannan backbone are responsible for assembly into the coating by Con A binding, while the galactose side chain residues are responsible for targeting to the liver-specific asialoglycoprotein receptor (ASGP-R). Binding to ASGP-R induces endocytic uptake, while the low endosomal pH triggers disassembly of the coating and release of the nanoparticle-entrapped drug. In vitro cell studies indicate that the coating confers liver-cell-specific function for both nanoparticle uptake and drug delivery. These studies extend the use of Con A to sugar-mediated and organ-specific targeting, and further illustrate the potential of biologically based fabrication for generating functional materials.</p>
DOI10.1002/adhm.201500202
Alternate JournalAdv Healthc Mater
PubMed ID26138108